We are live on
!
Find out more
CS
Candriam SCA Portfolio holdings
AUM
$19.3B
1-Year Est. Return
39.18%
This Fund
S&P 500
This Quarter
Est. Return
+5.67%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$4.78B
AUM Growth
–
Cap. Flow
+$4.65B
Cap. Flow
% of AUM
97.21%
Top 10 Holdings %
Top 10 Hldgs %
14.27%
Holding
616
New
605
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$91.9M |
| 2 |
CELG
Celgene Corp
CELG
|
+$79.7M |
| 3 |
Apple
AAPL
|
+$78.2M |
| 4 |
Qualcomm
QCOM
|
+$73.5M |
| 5 |
Amgen
AMGN
|
+$71.4M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.38% |
| 2 | Financials | 14.02% |
| 3 | Technology | 12.7% |
| 4 | Industrials | 8.01% |
| 5 | Energy | 6.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
O'Reilly Automotive
ORLY
$72.4B
| $1.01M | 0.02% |
+78,345
| New | +$918K |
|
427
Healthpeak Properties
DOC
$15.4B
| $996K | 0.02% |
+24,844
| New | +$986K |
|
428
Norfolk Southern
NSC
$78.8B
| $986K | 0.02% |
+8,991
| New | +$985K |
|
|
POT
429
DELISTED
Potash Corp Of Saskatchewan
POT
| $985K | 0.02% |
+27,800
| New | +$947K |
|
|
MHFI
430
DELISTED
MCGRAW-HILL FINANCIAL INC COM
MHFI
| $985K | 0.02% |
+11,068
| New | +$972K |
|
431
Cenovus Energy
CVE
$54.6B
| $976K | 0.02% |
+47,189
| New | +$1.09M |
|
|
VRN
432
DELISTED
Veren
VRN
| $958K | 0.02% |
+43,487
| New | +$1.19M |
|
|
AGEN
433
Agenus
AGEN
$249M
| $953K | 0.02% |
+12,228
| New | +$752K |
|
434
Aflac
AFL
$63.9B
| $951K | 0.02% |
+31,120
| New | +$919K |
|
|
RDHL
435
Redhill Biopharma
RDHL
$3.85M
| $945K | 0.02% |
+71
| New | +$736K |
|
|
PCYC
436
DELISTED
PHARMACYCLICS INC
PCYC
| $939K | 0.02% |
+7,677
| New | +$981K |
|
437
Bath & Body Works
BBWI
$4.01B
| $936K | 0.02% |
+13,373
| New | +$825K |
|
438
State Street
STT
$50.9B
| $936K | 0.02% |
+11,920
| New | +$895K |
|
|
ODP
439
DELISTED
ODP
ODP
| $926K | 0.02% |
+10,800
| New | +$687K |
|
440
Corning
GLW
$126B
| $925K | 0.02% |
+40,323
| New | +$821K |
|
441
Vale
VALE
$62.9B
| $898K | 0.02% |
+109,759
| New | +$1.03M |
|
|
MRSH
442
Marsh
MRSH
$86.3B
| $895K | 0.02% |
+15,640
| New | +$858K |
|
|
SCHW
443
Charles Schwab
SCHW
$177B
| $895K | 0.02% |
+29,643
| New | +$842K |
|
444
Akebia Therapeutics
AKBA
$327M
| $890K | 0.02% |
+76,485
| New | +$1.1M |
|
445
Sysco
SYY
$39.7B
| $869K | 0.02% |
+21,901
| New | +$849K |
|
446
Sarepta Therapeutics
SRPT
$1.66B
| $868K | 0.02% |
+60,000
| New | +$1.02M |
|
447
Dominion Energy
D
$62.5B
| $839K | 0.02% |
+10,905
| New | +$789K |
|
448
Verastem
VSTM
$532M
| $823K | 0.02% |
+7,500
| New | +$811K |
|
449
Equifax
EFX
$20.3B
| $813K | 0.02% |
+10,051
| New | +$777K |
|
450
Truist Financial
TFC
$63.2B
| $813K | 0.02% |
+20,908
| New | +$787K |
|
Similar funds
PCM
A
MGP
LF
SOMRS
BPA
MIM
Candriam SCA's Q4 2014 Portfolio in Review
Q4 2014 is the first quarter with a 13F filing on record for Candriam SCA, which disclosed 616 positions worth $4.78B. Its ten largest holdings account for 14% of the portfolio.
Its largest position is Gilead Sciences: 888,125 shares worth $83.7M.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, followed by Financials and Technology.
- Candriam SCA's largest Q4 2014 buy was Gilead Sciences: 888,125 shares worth $83.7M.
- Candriam SCA's ten largest holdings make up 14% of its $4.78B portfolio in Q4 2014.
- Candriam SCA disclosed 616 positions in Q4 2014, its first 13F filing on record.
Based on Candriam SCA's 13F filing for Q4 2014, filed 26 Mar 2015.